KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Other Non-Current Liabilities (2018 - 2026)

Takeda Pharmaceutical has reported Other Non-Current Liabilities over the past 9 years, most recently at $3.8 billion for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities rose 8.75% year-over-year to $3.8 billion; the TTM value through Mar 2026 reached $3.8 billion, up 8.75%, while the annual FY2026 figure was $4.0 billion, 13.12% up from the prior year.
  • Other Non-Current Liabilities was $3.8 billion for Q1 2026 at Takeda Pharmaceutical, up from $3.5 billion in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $3.8 billion in Q1 2026 and bottomed at $423.1 million in Q1 2023.
  • The 5-year median for Other Non-Current Liabilities is $546.2 million (2024), against an average of $1.7 billion.
  • Year-over-year, Other Non-Current Liabilities dropped 5.8% in 2023 and then skyrocketed 539.84% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $449.2 million in 2022, then decreased by 5.8% to $423.1 million in 2023, then increased by 29.08% to $546.2 million in 2024, then skyrocketed by 539.84% to $3.5 billion in 2025, then rose by 8.75% to $3.8 billion in 2026.
  • The last three reported values for Other Non-Current Liabilities were $3.8 billion (Q1 2026), $3.5 billion (Q1 2025), and $546.2 million (Q1 2024) per Business Quant data.